{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:15:34Z","timestamp":1761894934605},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,8,11]],"date-time":"2009-08-11T00:00:00Z","timestamp":1249948800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00198-009-1012-0","type":"journal-article","created":{"date-parts":[[2009,8,10]],"date-time":"2009-08-10T09:08:50Z","timestamp":1249895330000},"page":"705-708","source":"Crossref","is-referenced-by-count":19,"title":["Bisphosphonate-associated femoral fracture: implications for management in patients with malignancies"],"prefix":"10.1007","volume":"21","author":[{"given":"N.","family":"Napoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Novack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Armamento-Villareal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,11]]},"reference":[{"issue":"3","key":"1012_CR1","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"CV Odvina","year":"2005","unstructured":"Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90(3):1294\u20131301","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"1012_CR2","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMc062268","volume":"355","author":"R Armamento-Villareal","year":"2006","unstructured":"Armamento-Villareal R, Napoli N, Panwar V, Novack D (2006) Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis. N Engl J Med 355(19):2048\u20132050","journal-title":"N Engl J Med"},{"issue":"8","key":"1012_CR3","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1210\/jc.2007-2803","volume":"93","author":"M Visekruna","year":"2008","unstructured":"Visekruna M, Wilson D, McKiernan FE (2008) Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab 93(8):2948\u20132952","journal-title":"J Clin Endocrinol Metab"},{"key":"1012_CR4","doi-asserted-by":"crossref","unstructured":"Odvina CV, Levy S, Rao S, Zerwekh JE, Sudhaker RD. Unusual mid-shaft fractures during long term bisphosphonate therapy. Clin Endocrinol (Oxf) 2009, March 19","DOI":"10.1111\/j.1365-2265.2009.03581.x"},{"issue":"17","key":"1012_CR5","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2007.12.1269","volume":"25","author":"RA Kyle","year":"2007","unstructured":"Kyle RA, Yee GC, Somerfield MR et al (2007) American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol 25(17):2464\u20132472","journal-title":"J Clin Oncol"},{"issue":"8","key":"1012_CR6","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/cncr.11701","volume":"98","author":"LS Rosen","year":"2003","unstructured":"Rosen LS, Gordon D, Kaminski M et al (2003) Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer 98(8):1735\u20131744","journal-title":"Cancer"},{"issue":"5","key":"1012_CR7","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z","volume":"88","author":"A Lipton","year":"2000","unstructured":"Lipton A, Theriault RL, Hortobagyi GN et al (2000) Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials. Cancer 88(5):1082\u20131090","journal-title":"Cancer"},{"key":"1012_CR8","doi-asserted-by":"crossref","unstructured":"Cook JR (2008) Meta-analysis of effects of zoledronic acid (ZOL) on survival in metastatic bone disease (MBD). Abstract, 2008 ASCO Annual Meeting","DOI":"10.1200\/jco.2008.26.15_suppl.20562"},{"key":"1012_CR9","doi-asserted-by":"crossref","unstructured":"Lenart BA, Neviaser AS, Lyman S et al. (2009) Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int 20:1353\u20131362","DOI":"10.1007\/s00198-008-0805-x"},{"issue":"1","key":"1012_CR10","first-page":"31","volume":"61","author":"JP Schneider","year":"2006","unstructured":"Schneider JP (2006) Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate. Geriatrics 61(1):31\u201333","journal-title":"Geriatrics"},{"issue":"12","key":"1012_CR11","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMc0707493","volume":"358","author":"BA Lenart","year":"2008","unstructured":"Lenart BA, Lorich DG, Lane JM (2008) Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 358(12):1304\u20131306","journal-title":"N Engl J Med"},{"issue":"2","key":"1012_CR12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","volume":"39","author":"EB Kwek","year":"2008","unstructured":"Kwek EB, Goh SK, Koh JS, Png MA, Howe TS (2008) An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury 39(2):224\u2013231","journal-title":"Injury"},{"issue":"3","key":"1012_CR13","first-page":"349","volume":"89","author":"SK Goh","year":"2007","unstructured":"Goh SK, Yang KY, Koh JS et al (2007) Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br 89(3):349\u2013353","journal-title":"J Bone Joint Surg Br"},{"issue":"4","key":"1012_CR14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","volume":"15","author":"T Mashiba","year":"2000","unstructured":"Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15(4):613\u2013620","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1012_CR15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S8756-3282(01)00575-0","volume":"29","author":"T Mashiba","year":"2001","unstructured":"Mashiba T, Turner CH, Hirano T et al (2001) Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures. Bone 29(3):271\u2013278","journal-title":"Bone"},{"issue":"1\u20132","key":"1012_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0047-6374(98)00119-5","volume":"106","author":"AJ Bailey","year":"1998","unstructured":"Bailey AJ, Paul RG, Knott L (1998) Mechanisms of maturation and ageing of collagen. Mech Ageing Dev 106(1\u20132):1\u201356","journal-title":"Mech Ageing Dev"},{"issue":"31","key":"1012_CR17","doi-asserted-by":"crossref","first-page":"14557","DOI":"10.1016\/S0021-9258(18)66906-6","volume":"261","author":"CM Gundberg","year":"1986","unstructured":"Gundberg CM, Anderson M, Dickson I, Gallop PM (1986) \"Glycated\" osteocalcin in human and bovine bone. The effect of age. J Biol Chem 261(31):14557\u201314561","journal-title":"J Biol Chem"},{"issue":"2","key":"1012_CR18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S8756-3282(00)00434-8","volume":"28","author":"D Vashishth","year":"2001","unstructured":"Vashishth D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP (2001) Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 28(2):195\u2013201","journal-title":"Bone"},{"issue":"6","key":"1012_CR19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00198-008-0754-4","volume":"20","author":"SY Tang","year":"2009","unstructured":"Tang SY, Allen MR, Phipps R, Burr DB, Vashishth D (2009) Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. Osteoporos Int 20(6):887\u2013894","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-009-1012-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-009-1012-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-009-1012-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T14:15:04Z","timestamp":1633788904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-009-1012-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,11]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s00198-009-1012-0","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,11]]}}}